Articles tagged with: pre-exposure prophylaxis (PrEP)

‘Blood disgust’ is nothing new to people with HIV

published: July, 12, 2017 Written by // Mark S. King - My Fabulous Disease Categories // Social Media, Gay Men, Mental Health, Health, International , Living with HIV, Media, Opinion Pieces, Population Specific , Mark S. King

Mark S. King: "Unrealistic fear of HIV blood isn’t limited to the history books. HIV criminalization... preys upon outdated fears and public disgust with people living with the virus."

‘Blood disgust’ is nothing new to people with HIV

It is coursing through our veins, sustaining life and fighting disease, and yet we fear it. The sight of a few drops can make an adult faint. A bucket of it in a movie is the very definition of horror. Even as Donald Trump contributes his perverted, sexist new layer of blood revulsion (through a history of insults that include journalist Megyn Kelly’s bloody “whatever” and his most recent fabrication about a “bleeding” face lift that cable news anchor Mika Brzezinski never had)

We've got the tools right now. Let's end the HIV epidemic.

published: July, 10, 2017 Written by // T.J. Miller Categories // Aging, Social Media, Activism, As Prevention , T.J. Miller, Gay Men, Treatment Guidelines -including when to start, Health, International , Treatment, Living with HIV, Media, Opinion Pieces

"I was on the front lines of the battle in the early days, and I still am on the battle lines today as an advocate." PositiveLite.com welcomes longtime health care provider and HIV advocate T. J. Miller.

We've got the tools right now. Let's end the HIV epidemic.

This was the first article that appeared in the New York Times, that told us about the devastation, the Hell that was to come. 35 years later, while we have treatments, preventative medications (PrEP) and now concrete scientific evidence that persons with HIV who have an undetectable viral load for six months or greater are unable to transmit the virus to sexual partners (Undetectable=Untransmittable/Treatment as Prevention or TasP) we are still suffering with stigma, arguing over funding, de

Surprise FDA approval of generic Truvada is a 'wakeup call' for activists

published: July, 10, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, Activism, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Women, International , Revolving Door, Treatment, Media, Guest Authors

Advocates and doctors are scrambling to understand exactly when the generic will become available and how much it will cost. From TheBody.com, Sony Salzman reports.

Surprise FDA approval of generic Truvada is a 'wakeup call' for activists

To read the complete article by Sony Salzman, vsit TheBody.com, here. The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become available and how much it will cost. After weeks of speculation, both of those questions remain unanswered -- locked behind a confidential settlement agreement between TEVA,

“I would not have consented to sex had I known of their HIV status.” This statement is problematic and here’s why.

published: July, 05, 2017 Written by // Samantha Categories // Social Media, Conferences, Current Affairs, Women, Mental Health, Legal, Living with HIV, Media, Opinion Pieces, Population Specific , Samantha

"How can the general public insist upon disclosure when they set the tone and grounds for unsuccessful disclosure?" Samantha offers her takeaway from " Rethinking Justice: the 7th Symposium on HIV Law and Human Rights."

 “I would not have consented to sex had I known of their HIV status.” This statement is problematic and here’s why.

On June 15, 2017 the Canadian HIV/AIDS Legal Network held a symposium in Toronto, Ontario, Rethinking Justice: the 7th Symposium on HIV Law and Human Rights. The symposium focused on unjust HIV criminal legislation in Canada. Canada unfortunately has one of the worst records in the world for the overly broad use of criminal laws to address HIV nondisclosure. Panels of experts and those with lived experience of HIV criminalization presented their research and experiences. The legal experts di

Join us: community response to the effects of HIV treatment and viral suppression on sexual transmission – webinar

published: June, 27, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, General Health, Mental Health, Research, Health, International , Revolving Door, Treatment, Media, Guest Authors

Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, US Department of Health and Human Services invites you to attend. Scroll down for the registration link.

Join us: community response to the effects of HIV treatment and viral suppression on sexual transmission – webinar

On Friday, June 30, 2017 from 1:00 – 3:00 pm ET, the Office of HIV/AIDS and Infectious Disease Policy will host a community led “Community Response to the Effects of HIV Treatment and Viral Suppression on Transmission” webinar. To register CLICK HERE In the last year, compelling new evidence has demonstrated that HIV treatment significantly reduces sexual transmission of HIV. In addition, this research found no cases of HIV that were transmitted sexually by individuals with a suppress

Horwath hosts Pharmacare roundtable focused on tackling barriers to HIV prevention, treatment

published: June, 22, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, Treatment, Revolving Door, Media, Guest Authors

Horwath: “Whether it’s PrEP or HIV treatment, we believe that no one should have to empty their wallet to get the medicine they need,”

Horwath hosts Pharmacare roundtable focused on tackling barriers to HIV prevention, treatment

QUEEN’S PARK – Today (June 20, 2017) , Ontario NDP leader Andrea Horwath hosted a roundtable discussion with people living with HIV and leaders in the fight to improve access to HIV treatment and prevention in Ontario. A key topic during the discussion was the cost of life-saving drugs to treat and prevent HIV, and the NDP Pharmacare plan.  “Whether it’s PrEP or HIV treatment, we believe that no one should have to empty their wallet to get the medicine they need,” said Horwath.

FDA approves a generic form of PrEP

published: June, 16, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Youth, Current Affairs, Treatment Guidelines -including when to start, Women, International , Revolving Door, Treatment, Media, Guest Authors

Sexual health advocates hope this will make widen access to PrEP, the medication that helps prevent people contracting HIV

FDA approves a generic form of PrEP

To read the complete article by David Hudson visit Gay Star News, here. The Food and Drug Administration (FDA) in the US has approved the first generic form of PrEP. PrEP is medication that can be taken by someone to prevent them becoming infected with HIV. It’s a daily pill of Truvada, produced by Gilead Sciences. Truvada is a combination of Emtricitabine and Tenofovir Disoproxil Fumarate The use of PrEP has been credited with driving down HIV infection rates in countries where it has

Swiss Grindr survey finds 50% want to use PrEP in the next six months

published: June, 14, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, Dating, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, General Health, Health, International , Lifestyle, Treatment, Revolving Door, Media, Guest Authors

From AIDSmap, Gus Cairns reports on a survey showing twice as much interest in PrEP as in surveys done last year

Swiss Grindr survey finds 50% want to use PrEP in the next six months

A survey of Swiss gay men and men who have sex with men recruited through the Grindr networking app has found that while only 4.3% had taken HIV pre-exposure prophylaxis (PrEP), 50% would consider taking it within the next six months and 79% would either take it some time in the future or want to learn more about it. The survey was a brief one both in terms of its appearance online (from 5 to 24 January this year) and in terms of its length (only ten questions taking, it was estimated,

Let’s take a look at how gay porn studios have changed their treatment of poz performers

published: June, 06, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Movies, Health, International , Lifestyle, Revolving Door, Living with HIV, Media, Guest Authors

What it means to be HIV-positive is changing and the porn world is not exempt. From Unicorn Booty, Daniel Villarreal reports.

Let’s take a look at how gay porn studios have changed their treatment of poz performers

To read the complete article by Daniel Villarreal, visit Unicorn Booty, here. Gay porn star, sex worker and gay sexual health advocate Kayden Gray just came out as HIV-positive on YouTube. When gay porn stars Rod Daily and Mason Wyler came out as positive back 2013 and 2011 respectively, their announcements effectively ended their porn careers. So we asked Harlan Yaffe, the editor-in-chief of the gay porn news and video site The Sword (NSFW) and Zachary Sire, the editor-in-chief of the

Many physicians are wary of providing HIV PrEP for young people

published: May, 31, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Youth, Treatment Guidelines -including when to start, Women, Health, International , Revolving Door, Treatment, Media, Guest Authors

From AIDSmap, Liz Highleyman reports: "While 42% of the physicians overall said they were highly or somewhat likely to recommend PrEP, only 34% said they were likely to actually prescribe it."

Many physicians are wary of providing HIV PrEP for young people

Tanya Mullins at the Pediatric Academic Societies Meeting. Photo by Liz Highleyman, hivandhepatitis.com Only about a third of family practice and paediatric providers said they would be likely to prescribe HIV pre-exposure prophylaxis (PrEP) to adolescent patients, underlining the need to educate providers outside the HIV and sexually transmitted disease fields, according to a report at the 2017 Pediatric Academic Societies Meeting last week in San Francisco. Tanya Mullins of Cincinnati Chil

<<  1 2 3 4 [56 7 8 9  >>